lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling.

Pan J, Fang S, Tian H, Zhou C, Zhao X, Tian H, He J, Shen W, Meng X, Jin X, Gong Z. · 2020

Read lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling. by Pan J, Fang S, Tian H, Zhou C, Zhao X, Tian H, He J, Shen W, Meng X, Jin X, Gong Z. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6961326.txt.

Introduction

Pan and co-authors trace a chain of RNAs that helps lung cancer spread. Their study appeared in Molecular Cancer. Lung cancer kills largely by metastasis. Long non-coding RNAs are known players in cancer, but their grip on one spread-promoting protein, Twist1, was unclear.

A long RNA named JPX ran high in lung cancer tissue that had spread. High levels tracked with larger tumours and later stage. JPX boosted cancer cell growth in dishes and tumour growth in animals. It did so by sponging up a small RNA, miR-33a-5p, which normally restrains Twist1. Freed Twist1 then drove shape changes that let cells invade, through the Wnt/β-catenin pathway. Blocking JPX, the authors suggest, could become a targeted way to slow lung cancer spread.

Catalog record

CREATORPan J, Fang S, Tian H, Zhou C, Zhao X, Tian H, He J, Shen W, Meng X, Jin X, Gong Z.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6961326

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/β-catenin signaling By Jinchang Pan, Shuai Fang, Haihua Tian, Chengwei Zhou, Xiaodong Zhao, Hui Tian, Jinxian He, Weiyu Shen, Xiaodan Meng, Xiaofeng Jin, Zhaohui Gong Published in: Molecular Cancer DOI: 10.1186/s12943-020-1133-9 ABSTRACT Abstract Background MicroRNAs (miRNAs) and Twist1-induced epithelial-mesenchymal transition (EMT) in cancer cell dissemination are well established, but the involvement of long noncoding RNAs (lncRNAs) in Twist1-mediated signaling remains largely unknown. Methods RT-qPCR and western blotting were conducted to detect the expression levels of lncRNA JPX and Twist1 in lung cancer cell lines and tissues. The impact of JPX on Twist1 expression, cell growth, invasion, apoptosis, and in vivo tumor growth were investigated in lung cancer cells by western blotting, rescue experiments, colony formation assay, flow cytometry, and xenograft animal experiment. Results We observed that lncRNA JPX was upregulated in lung cancer metastatic tissues and was closely correlated with tumor size and an advanced stage. Functionally, JPX promoted lung cancer cell proliferation in vitro and facilitated lung tumor growth in vivo. Additionally, JPX upregulated Twist1 by competitively sponging miR-33a-5p and subsequently induced EMT and lung cancer cell invasion. Interestingly, JPX and Twist1 were coordinately upregulated in lung cancer tissues and cells. Mechanically, the JPX/miR-33a-5p/Twist1 axis participated in EMT progression by activating Wnt/β-catenin signaling. Conclusions These findings suggest that lncRNA JPX, a mediator of Twist1 signaling, could predispose lung cancer cells to metastasis and may serve as a potential target for targeted therapy. Keywords: Epithelial-mesenchymal transition, Twist1, Long noncoding RNA, Wnt/β-catenin signaling, Lung cancer BACKGROUND Lung cancer is one of the most malignant of all cancer, and the 5-year survival rates vary from 4 to 17% depending on stage and regional differences [1, 2]. Although many advances have been made in the diagnosis and treatment of lung cancer in recent years, metastasis still remains the main challenge posed by advanced lung cancer leading to high mortality [3]. Thus, the elucidation of a new oncogenic pathway is required to precisely target lung cancer and to serve as a prognostic factor. Long noncoding RNAs (lncRNAs) are a class of RNA molecules longer than 200 nucleotides in length with considerable potential to drive cancer development [4–7]. Aberrantly expressed lncRNAs have been found to be associated with the occurrence and development of various types of cancers [8–10]. In addition, lncRNAs affect gene expression through various mechanisms in which lncRNAs regulate their target genes by acting as microRNA (miRNA) sponges, thereby affecting the growth, proliferation, migration, and invasion of cancer cells [11, 12]. In the lncRNA-miRNA-mRNA regulatory network, lncRNAs act as competitive endogenous RNAs (ceRNAs) of specific mRNAs [13]. Specifically, lncRNA SMAD5-AS1 could upregulate adenomatous polyposis coli expression by sponging miR-135b-5p and inactivate the canonical Wnt/β-catenin pathway to inhibit diffuse large B cell lymphoma proliferation [14]. Furthermore, lncRNA PVT1 was found to regulate hexokinase 2 (HK2) expression by competitively binding to endogenous miR-143 in gallbladder cancer (GBC) cells, suggesting an important role of the PVT1/miR-143/HK2 axis in cell proliferation and metastasis by modulating aerobic glucose metabolism in GBC cells [15]. However, the function and mechanism of most aberrantly expressed lncRNAs as ceRNAs in lung cancer remain unclear. Our previous work showed that miR-33a-5p negatively regulated Twist1, thus inhibiting the invasion and metastasis of non-small cell lung cancer (NSCLC) [16], and served as a potential biomarker for early lung cancer diagnosis [17]. Twist1 is an important transcription factor that mediates epithelial-mesenchymal transition (EMT) progression and tumor metastasis [18, 19]. In addition, Wnt/β-catenin signaling is a critical driver in EMT and cancer metastasis [20]. It has been found that miRNAs can participate in the EMT process by regulating the Wnt/β-catenin pathway in a variety of cancers [21, 22]. Therefore, we considered whether an lncRNA could form a ceRNA network with miR-33a-5p and Twist1 to participate in EMT and malignant processes in lung cancer. In the present study, we identified that JPX, an upregulated lncRNA in lung cancer, acted as a ceRNA for Twist1 through binding with miR-33a-5p. As an oncogene, JPX affected the tumor size, TNM staging, and metastasis of lung cancer. Functionally, JPX promoted cell proliferation, migration, and invasion and facilitated tumor growth in xenograft mouse model. Further assays revealed that JPX participated in the activation of Wnt/β-catenin signaling by regulating miR-33a-5p/Twist1, which in turn promoted the EMT process, ultimately influencing the of lung cancer process. The results indicate that the JPX/miR-33a-5p/Twist1 axis regulates lung carcinoma by activating Wnt/β-catenin signaling, suggesting a therapeutic potential for lung cancer treatment. METHODS Clinical subjects and specimens Total of 116 lung cancer tissues and corresponding adjacent tissues were collected from the Affiliated Hospital of Medical School of Ningbo University (Ningbo, China) and Ningbo Medical Center Lihuili Eastern Hospital (Ningbo, China). All of the patients were diagnosed with primary lung cancer and did not receive preoperative radiotherapy, chemotherapy, targeted therapy and immunotherapy. At the same time, general clinical information and detailed pathology records were collected. All patients received written informed consent and the study protocol was approved by the Clinical Research Ethics Committee of the Medical School of Ningbo University (Approval No.: NBUSM20171006). All experimental protocols were implemented in accordance with relevant regulations. RNA extraction and quantitative real-time PCR (RT-qPCR) Total RNA was isolated from lung cancer tissue and cells using Trizol reagent (Invitrogen, USA) following the manufacturer’s protocol. DeNovix DS-11 Spectrophotometer (DeNovix, USA) detects the purity and concentration of RNA. We synthesized cDNA by reverse transcription reaction using a ReverTra Ace qPCR RT Master Mix with gDNA Remove kit (Toyobo, Japan) or a commercial miRNA reverse transcription PCR kit (GenePharma, China). RT-qPCR was conducted using a SYBR Premix Ex Taq II (Takara, Japan) on a Mx3005P real-time PCR System (Stratagene, USA) according to manufacturer’s instructions. Results were normalized using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6 as an internal control. To account for the assessment of technical variability, the assays were performed in triplicate for each case. Primer sequences are shown in Additional file 1: Table S1. Cell culture and transfection All cell lines were obtained from the Chinese Academy of Sciences Cell Bank (CASCB, China), including 1 human normal bronchial epithelial cell (BEAS-2B) and 4 human lung adenocarcinoma cells (SPC-A-1, LTEP-a-2, A549, NCI-H1299). All human lung cancer cell lines were cultured in RPMI-1640 (Hyclone, USA), with 10% fetal bovine serum (PAN, Germany). BEAS-2B was maintained in Dulbecco’s modified Eagle’s medium (DMEM) that was supplemented with 10% FBS. All cell lines were placed in a cell culture incubator (Thermo Fisher, USA) containing 5% CO2 at 37 °C. JPX small interfering RNA (siRNA, GenePharma, China) and Twist1 siRNA with the corresponding control RNA (siRNA NC), or recombinant plasmid overexpressing JPX with the empty pcDNA3.1 vector (Tiandz, China), or miR-33a-5p mimics (GenePharma, China) with corresponding control RNA (mimics NC) were transfected into cells in logarithmic growth phase. The transfection was performed using the Lipofectamine 2000 transfection reagent (Invitrogen, USA) according to the manufacturer’s protocol. The transfected sequences of the miR-33a-5p mimics and siRNA oligonucleotides are shown in Additional file 1, Table S2. Recombinant plasmid construction The sequences of JPX was amplified by PCR from the genomic DNA of SPC-A1 cell line, and sub-cloned into the pcDNA3.1 vector or pGL3-control vector (Promega, USA) as described in our previous work [16]. The primer sequences

Read the complete text